Rasburicase as a Uricolytic Therapy for Hyperuricemia in Patients With Leukemia or Lymphoma
Clinical trial NCT00631579 · COMPLETED
Trial details
- NCT number
- NCT00631579
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-04-01
- Primary completion
- 2004-06-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.